383 related articles for article (PubMed ID: 28105558)
1. Immunology of Bee Venom.
Elieh Ali Komi D; Shafaghat F; Zwiener RD
Clin Rev Allergy Immunol; 2018 Jun; 54(3):386-396. PubMed ID: 28105558
[TBL] [Abstract][Full Text] [Related]
2. Hymenoptera venom allergy: analysis of double positivity to honey bee and Vespula venom by estimation of IgE antibodies to species-specific major allergens Api m1 and Ves v5.
Müller UR; Johansen N; Petersen AB; Fromberg-Nielsen J; Haeberli G
Allergy; 2009 Apr; 64(4):543-8. PubMed ID: 19120073
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of a therapeutic treatment using gas-filled microbubble-associated phospholipase A2 in a mouse model of honeybee venom allergy.
Corthésy B; Lassus A; Terrettaz J; Tranquart F; Bioley G
Allergy; 2016 Jul; 71(7):957-66. PubMed ID: 26850222
[TBL] [Abstract][Full Text] [Related]
4. IgE-Api m 4 Is Useful for Identifying a Particular Phenotype of Bee Venom Allergy.
Ruiz B; Serrano P; Moreno C
J Investig Allergol Clin Immunol; 2016; 26(6):355-361. PubMed ID: 27996941
[TBL] [Abstract][Full Text] [Related]
5. Time course of serum inhibitory activity for facilitated allergen-IgE binding during bee venom immunotherapy in children.
Varga EM; Francis JN; Zach MS; Klunker S; Aberer W; Durham SR
Clin Exp Allergy; 2009 Sep; 39(9):1353-7. PubMed ID: 19538349
[TBL] [Abstract][Full Text] [Related]
6. rApi m 3 and rApi m 10 improve detection of honey bee sensitization in Hymenoptera venom-allergic patients with double sensitization to honey bee and yellow jacket venom.
Frick M; Müller S; Bantleon F; Huss-Marp J; Lidholm J; Spillner E; Jakob T
Allergy; 2015 Dec; 70(12):1665-8. PubMed ID: 26259841
[TBL] [Abstract][Full Text] [Related]
7. Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom.
Müller U; Akdis CA; Fricker M; Akdis M; Blesken T; Bettens F; Blaser K
J Allergy Clin Immunol; 1998 Jun; 101(6 Pt 1):747-54. PubMed ID: 9648701
[TBL] [Abstract][Full Text] [Related]
8. Hymenoptera venom allergy in humans.
Cichocka-Jarosz E
Folia Med Cracov; 2012; 52(3-4):43-60. PubMed ID: 24852686
[TBL] [Abstract][Full Text] [Related]
9. High-dose bee venom exposure induces similar tolerogenic B-cell responses in allergic patients and healthy beekeepers.
Boonpiyathad T; Meyer N; Moniuszko M; Sokolowska M; Eljaszewicz A; Wirz OF; Tomasiak-Lozowska MM; Bodzenta-Lukaszyk A; Ruxrungtham K; van de Veen W
Allergy; 2017 Mar; 72(3):407-415. PubMed ID: 27341567
[TBL] [Abstract][Full Text] [Related]
10. Individual hymenoptera venom compounds induce upregulation of the basophil activation marker ectonucleotide pyrophosphatase/phosphodiesterase 3 (CD203c) in sensitized patients.
Binder M; Fierlbeck G; King Ti; Valent P; Bühring HJ
Int Arch Allergy Immunol; 2002 Oct; 129(2):160-8. PubMed ID: 12403934
[TBL] [Abstract][Full Text] [Related]
11. Agreement of skin test with IL-4 production and CD40L expression by T cells upon immunotherapy of subjects with systemic reactions to Hymenoptera stings.
Urra JM; Cabrera CM; Alfaya T; Feo-Brito F
Mol Immunol; 2016 Feb; 70():134-9. PubMed ID: 26774053
[TBL] [Abstract][Full Text] [Related]
12. The putative serine protease inhibitor Api m 6 from Apis mellifera venom: recombinant and structural evaluation.
Michel Y; McIntyre M; Ginglinger H; Ollert M; Cifuentes L; Blank S; Spillner E
J Investig Allergol Clin Immunol; 2012; 22(7):476-84. PubMed ID: 23397669
[TBL] [Abstract][Full Text] [Related]
13. Value of component based diagnostics in IgE-mediated hymenoptera sting reactions.
Neis MM; Merk HF
Cutan Ocul Toxicol; 2012 Jun; 31(2):117-23. PubMed ID: 21995714
[TBL] [Abstract][Full Text] [Related]
14. Systemic and local reactions of bee venom immunotherapy in Iran.
Bemanian MH; Farhoudi A; Pourpak Z; Gharagozlou M; Movahedi M; Nabavi M; Mozafari H; Mohammadzadeh I; Chavoshzadeh Z; Shirkhoda Z
Iran J Allergy Asthma Immunol; 2007 Dec; 6(4):203-6. PubMed ID: 18094443
[TBL] [Abstract][Full Text] [Related]
15. Component resolution reveals additional major allergens in patients with honeybee venom allergy.
Köhler J; Blank S; Müller S; Bantleon F; Frick M; Huss-Marp J; Lidholm J; Spillner E; Jakob T
J Allergy Clin Immunol; 2014 May; 133(5):1383-9, 1389.e1-6. PubMed ID: 24440283
[TBL] [Abstract][Full Text] [Related]
16. Elevated and cross-responsive CD1a-reactive T cells in bee and wasp venom allergic individuals.
Subramaniam S; Aslam A; Misbah SA; Salio M; Cerundolo V; Moody DB; Ogg G
Eur J Immunol; 2016 Jan; 46(1):242-52. PubMed ID: 26518614
[TBL] [Abstract][Full Text] [Related]
17. Enzymatic activity of soluble phospholipase A2 does not affect the specific IgE, IgG4 and cytokine responses in bee sting allergy.
Wymann D; Akdis CA; Blesken T; Akdis M; Crameri R; Blaser K
Clin Exp Allergy; 1998 Jul; 28(7):839-49. PubMed ID: 9720818
[TBL] [Abstract][Full Text] [Related]
18. Antibodies to purified bee venom proteins and peptides. I. Development of a highly specific RAST for bee venom antigens and its application to bee sting allergy.
Kemeny DM; Harries MG; Youlten LJ; Mackenzie-Mills M; Lessof MH
J Allergy Clin Immunol; 1983 May; 71(5):505-14. PubMed ID: 6601672
[TBL] [Abstract][Full Text] [Related]
19. Bee sting allergy in beekeepers.
Eich-Wanger C; Müller UR
Clin Exp Allergy; 1998 Oct; 28(10):1292-8. PubMed ID: 9824397
[TBL] [Abstract][Full Text] [Related]
20. Allergy to honeybee … not only stings.
Cifuentes L
Curr Opin Allergy Clin Immunol; 2015 Aug; 15(4):364-8. PubMed ID: 26110688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
